Anaplastic Thyroid Cancer Latest Advances

Heparanase-responsive nanomaterial for anaplastic thyroid cancer chemotherapy.

Journal: Nanoscale

Published: September 30, 2025

Prognostic Factors in Thyroid Cancer Patients With Brain Metastases: A Systematic Review and Meta-Analysis.

Journal: Thyroid : official journal of the American Thyroid Association

Published: September 16, 2025

Targeting B7-H3 in Cancer-Associated Fibroblasts Using Nanosystems Suppresses Anaplastic Thyroid Carcinoma Progression.

Journal: Thyroid : official journal of the American Thyroid Association

Published: September 02, 2025

Immunotherapy in Initial Treatment of Anaplastic Thyroid Cancer: Evaluation of Overall Survival in a National Cancer Database Study.

Journal: Thyroid : official journal of the American Thyroid Association

Published: September 02, 2025

Advances in the treatment of anaplastic thyroid carcinoma

Journal: Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery

Published: August 24, 2025

Immunophenotypic Panel for Comprehensive Characterization of Aggressive Thyroid Carcinomas.

Journal: Cells

Published: August 21, 2025

Disease-Specific and Histological Outcomes of Preoperative TERT Promoter Mutation Detected in Isolation or in Combination with Other Mutations in Thyroid Neoplasms.

Journal: Thyroid : official journal of the American Thyroid Association

Published: August 20, 2025

Loss of tumor cell MHC Class II drives MAPK-inhibitor insensitivity of BRAF-mutant anaplastic thyroid cancers.

Journal: The Journal of clinical investigation

Published: August 19, 2025

Analysis of factors affecting long-term survival in patients with anaplastic thyroid carcinoma and the efficacy of immunotherapy

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]

Published: August 14, 2025

Giant non-functioning adrenocortical carcinoma: a case report and literature review.

Journal: Chinese clinical oncology

Published: August 11, 2025

Single-cell transcriptome analysis reveals the potential heterogeneous mechanism of CD8+ T cell immune dysfunction in thyroid cancer.

Journal: Scientific reports

Published: August 04, 2025

Pathological Diagnosis of Thyroid Nodules with Preoperatively Detected TERT Promoter Mutations in the Absence of BRAFV600E: A Bi-Center Series of 52 Cases.

Journal: Thyroid : official journal of the American Thyroid Association

Published: July 28, 2025

Filters

Heparanase-responsive nanomaterial for anaplastic thyroid cancer chemotherapy.

Heparanase-responsive nanomaterial for anaplastic thyroid cancer chemotherapy.

Prognostic Factors in Thyroid Cancer Patients With Brain Metastases: A Systematic Review and Meta-Analysis.

Prognostic Factors in Thyroid Cancer Patients With Brain Metastases: A Systematic Review and Meta-Analysis.

Targeting B7-H3 in Cancer-Associated Fibroblasts Using Nanosystems Suppresses Anaplastic Thyroid Carcinoma Progression.

Targeting B7-H3 in Cancer-Associated Fibroblasts Using Nanosystems Suppresses Anaplastic Thyroid Carcinoma Progression.

Immunotherapy in Initial Treatment of Anaplastic Thyroid Cancer: Evaluation of Overall Survival in a National Cancer Database Study.

Immunotherapy in Initial Treatment of Anaplastic Thyroid Cancer: Evaluation of Overall Survival in a National Cancer Database Study.

Advances in the treatment of anaplastic thyroid carcinoma

Advances in the treatment of anaplastic thyroid carcinoma

Immunophenotypic Panel for Comprehensive Characterization of Aggressive Thyroid Carcinomas.

Immunophenotypic Panel for Comprehensive Characterization of Aggressive Thyroid Carcinomas.

Disease-Specific and Histological Outcomes of Preoperative TERT Promoter Mutation Detected in Isolation or in Combination with Other Mutations in Thyroid Neoplasms.

Disease-Specific and Histological Outcomes of Preoperative TERT Promoter Mutation Detected in Isolation or in Combination with Other Mutations in Thyroid Neoplasms.

Loss of tumor cell MHC Class II drives MAPK-inhibitor insensitivity of BRAF-mutant anaplastic thyroid cancers.

Loss of tumor cell MHC Class II drives MAPK-inhibitor insensitivity of BRAF-mutant anaplastic thyroid cancers.

Analysis of factors affecting long-term survival in patients with anaplastic thyroid carcinoma and the efficacy of immunotherapy

Analysis of factors affecting long-term survival in patients with anaplastic thyroid carcinoma and the efficacy of immunotherapy

Giant non-functioning adrenocortical carcinoma: a case report and literature review.

Giant non-functioning adrenocortical carcinoma: a case report and literature review.

Single-cell transcriptome analysis reveals the potential heterogeneous mechanism of CD8+ T cell immune dysfunction in thyroid cancer.

Single-cell transcriptome analysis reveals the potential heterogeneous mechanism of CD8+ T cell immune dysfunction in thyroid cancer.

Pathological Diagnosis of Thyroid Nodules with Preoperatively Detected TERT Promoter Mutations in the Absence of BRAFV600E: A Bi-Center Series of 52 Cases.

Pathological Diagnosis of Thyroid Nodules with Preoperatively Detected TERT Promoter Mutations in the Absence of BRAFV600E: A Bi-Center Series of 52 Cases.